Literature DB >> 15629353

Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx.

S J Cox1, C Voyce, S Parida, S M Reid, P A Hamblin, D J Paton, P V Barnett.   

Abstract

The ability of emergency foot-and-mouth disease (FMD) vaccine to protect cattle from a heterologous direct-contact challenge and the effect on virus excretion from the oropharynx were examined. An oil adjuvant O1 Manisa FMD vaccine protected 20 cattle from clinical disease following 5 days of direct-contact exposure to five infected cattle at 21 days post vaccination. The donor cattle had been infected by tongue inoculation with a different FMD virus of the same serotype (O UKG 2001). Protection from clinical disease did not prevent localised sub-clinical infection at the oropharynx in most animals, although quantitative reverse transcriptase polymerase chain reaction (RT-PCR) showed that the level of virus replication shortly after direct-contact challenge was greatly reduced in vaccinated animals. Nevertheless, 45% of the vaccinated cattle became persistently infected with 10(3)-10(6) RNA copies per millilitre of oropharyngeal fluid at 28 days post challenge. However, since live virus could not be readily isolated, the risk of these animals transmitting disease was probably very low. The findings show that even after an extremely severe challenge, use of an emergency vaccine will prevent or reduce local virus replication and thereby dramatically reduce the amount of virus released into the environment in the all-important early post-exposure period. These data should help to model the dynamics of virus transmission in future outbreaks of disease where vaccination is considered.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15629353     DOI: 10.1016/j.vaccine.2004.08.034

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  23 in total

1.  Modeling the spread and control of foot-and-mouth disease in Pennsylvania following its discovery and options for control.

Authors:  Michael J Tildesley; Gary Smith; Matt J Keeling
Journal:  Prev Vet Med       Date:  2011-12-12       Impact factor: 2.670

2.  Protection against direct in-contact challenge following foot-and-mouth disease vaccination in sheep and goats: the effect on virus excretion and carrier status.

Authors:  Muthukrishnan Madhanmohan; Singanallur Balasubramanian Nagendrakumar; Villuppanoor Alwar Srinivasan
Journal:  Vet Res Commun       Date:  2010-03-30       Impact factor: 2.459

3.  The effect of foot-and-mouth disease (FMD) vaccination on virus transmission and the significance for the field.

Authors:  Karin Orsel; Annemarie Bouma
Journal:  Can Vet J       Date:  2009-10       Impact factor: 1.008

4.  Use of a standardized bovine serum panel to evaluate a multiplexed nonstructural protein antibody assay for serological surveillance of foot-and-mouth disease.

Authors:  Julie Perkins; Satya Parida; Alfonso Clavijo
Journal:  Clin Vaccine Immunol       Date:  2007-10-03

5.  Modelling studies to estimate the prevalence of foot-and-mouth disease carriers after reactive vaccination.

Authors:  M E Arnold; D J Paton; E Ryan; S J Cox; J W Wilesmith
Journal:  Proc Biol Sci       Date:  2008-01-07       Impact factor: 5.349

6.  Development of a competitive enzyme-linked immunosorbent assay for detection of antibodies against the 3B protein of foot-and-mouth disease virus.

Authors:  Ming Yang; Satya Parida; Tim Salo; Kate Hole; Lauro Velazquez-Salinas; Alfonso Clavijo
Journal:  Clin Vaccine Immunol       Date:  2015-02-04

7.  A Brief Review on Diagnosis of Foot-and-Mouth Disease of Livestock: Conventional to Molecular Tools.

Authors:  Neeta Longjam; Rajib Deb; A K Sarmah; Tilling Tayo; V B Awachat; V K Saxena
Journal:  Vet Med Int       Date:  2011-07-06

Review 8.  Experimental evaluation of foot-and-mouth disease vaccines for emergency use in ruminants and pigs: a review.

Authors:  Sarah J Cox; Paul V Barnett
Journal:  Vet Res       Date:  2008-12-02       Impact factor: 3.683

9.  Engineering foot-and-mouth disease viruses with improved growth properties for vaccine development.

Authors:  Haixue Zheng; Jianhong Guo; Ye Jin; Fan Yang; Jijun He; Lv Lv; Kesan Zhang; Qiong Wu; Xiangtao Liu; Xuepeng Cai
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

10.  Pandemic strain of foot-and-mouth disease virus serotype O.

Authors:  Nick J Knowles; Alan R Samuel; Paul R Davies; Rebecca J Midgley; Jean-François Valarcher
Journal:  Emerg Infect Dis       Date:  2005-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.